欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Toyocamycin_606-58-6_产品详情
606-58-6
  • names:

    Toyocamycin

  • CAS号:

    606-58-6

    MDL Number:
  • MF(分子式): C12H13N5O4 MW(分子量): 291.26
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Toyocamycin
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002515-10mg 10mg >97% ¥ 1012.50 ¥ 1012.50 Instock2-3days
- +
¥ 0.00
YZM002515-5mg 5mg >97% ¥ 650.00 ¥ 650.00 Instock2-3days
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 杀菌剂; 西罗霉素; 氰基结核菌素
英文别名 Vengicide; Siromycin; Cyanotubericidin; Ahygroscopin-B;Antibiotic 1037, Antibiotic A-399-Y4, Antibiotic E212, Siromycin, Toyocamycin
CAS号 606-58-6
Inchi 1S/C12H13N5O4/c13-1-5-2-17(11-7(5)10(14)15-4-16-11)12-9(20)8(19)6(3-18)21-12/h2,4,6,8-9,12,18-20H,3H2,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1
InchiKey XOKJUSAYZUAMGJ-WOUKDFQISA-N
分子式 Formula C12H13N5O4
分子量 Molecular Weight 291.26
溶解度Solubility
性状 White to Fawn Solid
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.


Toyocamycin(CAS:606-58-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Toyocamycin (Vengicide) 为放线菌类产生的腺苷类似物,为 X 盒结合蛋白 1 (XBP1) 抑制剂,抑制 IRE1α 诱导的 ATP 依赖性 XBP1 mRNA 的断裂,IC50值为 80 nM
IntroductionToyocamycin (Vengicide) is an adenosine analog produced byActinomycete, acts as anXBP1inhibitor, inhibits IRE1αnduced ATPependent XBP1 mRNA cleavage, with anIC50of 80 nM. Toyocamycin (Vengicide) induces apoptosis. Toyocamycin (Vengicide) shows no effect on IRE1α autohosphorylation.
Application1
Application2
Application3
Toyocamycin (Vengicide) 为放线菌类产生的腺苷类似物,为 X 盒结合蛋白 1 (XBP1) 抑制剂,抑制 IRE1α 诱导的 ATP 依赖性 XBP1 mRNA 的断裂,IC50值为 80 nM。Toyocamycin (Vengicide) 诱导凋亡,对 IRE1α 的自身磷酸化没有作用。
Toyocamycin (Vengicide) is an adenosine analog produced byActinomycete, acts as anXBP1inhibitor, inhibits IRE1α-induced ATP-dependent XBP1 mRNA cleavage, with anIC50of 80 nM. Toyocamycin (Vengicide) induces apoptosis. Toyocamycin (Vengicide) shows no effect on IRE1α auto-phosphorylation[1].
Toyocamycin is a pyrrolopyrimidine nucleoside isolated from streptomyces toyocaensis, and also an adenosine nucleotide antimetabolite. It has a broad spectrum of action against bacteria, fungi, protozoans and mammalian cell lines.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Toyocamycin, et al. Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. Blood Cancer J. 2012 Jul;2(7):e79.

【2】. Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, Kanda Y, Taura N, Ohnita K, Takeshima F, Sakai Y, Eguchi S, Nakashima M, Nakao K. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One. 2017 Mar 9;12(3):e0170591. doi: 10.1371/journal.pone.0170591. eCollection 2017. PubMed PMID: 28278289; PubMed Central PMCID: PMC5344317.

【3】.Xu X, Wang J, Bechthold A, Ma Z, Yu X. Selection of an efficient promoter and its application in toyocamycin production improvement in Streptomyces diastatochromogenes 1628. World J Microbiol Biotechnol. 2017 Feb;33(2):30. doi: 10.1007/s11274-016-2194-1. Epub 2017 Jan 5. PubMed PMID: 28058639.

【4】.Park SG, Kim SH, Kim KY, Yu SN, Choi HD, Kim YW, Nam HW, Seo YK, Ahn SC. Toyocamycin induces apoptosis via the crosstalk between reactive oxygen species and p38/ERK MAPKs signaling pathway in human prostate cancer PC-3 cells. Pharmacol Rep. 2017 Feb;69(1):90-96. doi: 10.1016/j.pharep.2016.10.014. Epub 2016 Oct 24. PubMed PMID: 27912102.

【5】. Rayala R, Theard P, Ortiz H, Yao S, Young JD, Balzarini J, Robins MJ, Wnuk SF. Synthesis of purine and 7-deazapurine nucleoside analogues of 6-N-(4-Nitrobenzyl)adenosine; inhibition of nucleoside transport and proliferation of cancer cells. ChemMedChem. 2014 Sep;9(9):2186-92. doi: 10.1002/cmdc.201402047. Epub 2014 Apr 30. PubMed PMID: 24788480; PubMed Central PMCID: PMC4149842.

【6】. Kiburu IN, LaRonde-LeBlanc N. Interaction of Rio1 kinase with toyocamycin reveals a conformational switch that controls oligomeric state and catalytic activity. PLoS One. 2012;7(5):e37371. doi: 10.1371/journal.pone.0037371. Epub 2012 May 22. PubMed PMID: 22629386; PubMed Central PMCID: PMC3358306.

【7】.Hayashi K, Kamio S, Oono Y, Townsend LB, Nozaki H. Toyocamycin specifically inhibits auxin signaling mediated by SCFTIR1 pathway. Phytochemistry. 2009 Jan;70(2):190-7. doi: 10.1016/j.phytochem.2008.12.020. Epub 2009 Jan 24. PubMed PMID: 19171357.

    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents